1
|
Law YXT, Castellani D, Dell'atti L, Aho T, Teoh JYC, Gauhar V. Differences in surgical and functional outcomes in benign prostate hyperplasia patients with only lower urinary tract symptoms versus those in retention: A systematic review and meta-analysis. Neurourol Urodyn 2021; 40:1389-1401. [PMID: 34036628 DOI: 10.1002/nau.24708] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2021] [Revised: 05/08/2021] [Accepted: 05/10/2021] [Indexed: 12/23/2022]
Abstract
AIMS To evaluate outcomes after benign prostate hyperplasia (BPH) surgery among men with lower urinary tract symptoms (LUTS) only versus those with urinary retention (UR). METHODS The protocol was registered in PROSPERO with ID#232253. Eligible studies identified from four electronic databases. Search, data extraction and quality assessment were performed independently by two reviewers. Studies with perioperative, functional, early and late complication outcomes included. RESULTS Twenty-five studies, 14 593 patients including 1 randomized controlled trial, 11 prospective and 13 retrospective studies included for meta-analysis. This showed higher risk of immediate transient recatherization (risk ratio [RR]: 5.29, p < 0.00001), longer days to trial-off-catheter (mean difference [MD]: 0.25, p < 0.00001), longer hospitalization stay in the UR group (MD: 0.35, p < 0.00001), and higher risk of intraoperative blood transfusions (RR: 1.90, p = 0.002), postoperative urinary tract infections (RR: 1.49, p < 0.00001) and sepsis (RR: 8.15, p = 0.009) too. Failure of surgery like permanent recatheterization (RR: 5.27, p < 0.00001) was more in preoperative UR group. Negligible differences seen in long term functional outcomes between the two groups (International Prostate Symptom Score at 12 months, MD: -0.06, p = 0.68; Quality of Life at 12 months, MD: 0.20, p < 0.00001; maximum urinary flow rate at 12 months, MD: -0.33, p = 0.10; and postvoid residual volume at 12 months, MD: 4.32, p < 0.00001). CONCLUSIONS Preoperative UR patients undergoing surgery for BPH have higher risk of postoperative complications versus LUTS only group including the need for permanent catheterization. Both groups had similar long-term functional outcomes. We could infer that patients with UR on whom surgery is successful, with time may recover bladder function akin to patients with LUTS alone.
Collapse
Affiliation(s)
| | - Daniele Castellani
- Division of Urology, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Università Politecnica delle Marche, Ancona, Italy
| | - Lucio Dell'atti
- Division of Urology, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Università Politecnica delle Marche, Ancona, Italy
| | - Tevita Aho
- Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - Jeremy Yuen-Chun Teoh
- Department of Surgery, Faculty of Medicine, S.H. Ho Urology Center, The Chinese University of Hong Kong, Hong Kong, China
| | - Vineet Gauhar
- Department of Urology, Ng Teng Fong General Hospital, Singapore
| |
Collapse
|
2
|
Mu XN, Wang SJ, Chen J, Jin XB, Huang ZX, Zhang LY. Bipolar transurethral enucleation of prostate versus photoselective vaporization for symptomatic benign prostatic hyperplasia (>70 ml). Asian J Androl 2019; 19:608-612. [PMID: 27320474 PMCID: PMC5566858 DOI: 10.4103/1008-682x.178484] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Affiliation(s)
- Xiao-Nan Mu
- Cadres Integrative Unit 1, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, P. R. China
| | - Si-Jun Wang
- Department of Urology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, P. R. China
| | - Ji Chen
- Department of Minimally Invasive Urology, Provincial Hospital affiliated to Shandong University, Jinan 250021, Shandong, P. R. China
| | - Xun-Bo Jin
- Department of Minimally Invasive Urology, Provincial Hospital affiliated to Shandong University, Jinan 250021, Shandong, P. R. China
| | - Zhong-Xian Huang
- Department of Urology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, P. R. China
| | - Long-Yang Zhang
- Department of Urology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, P. R. China
| |
Collapse
|
3
|
Pascoe C, Ow D, Perera M, Woo HH, Jack G, Lawrentschuk N. Optimising patient outcomes with photoselective vaporization of the prostate (PVP): a review. Transl Androl Urol 2017; 6:S133-S141. [PMID: 28791232 PMCID: PMC5522804 DOI: 10.21037/tau.2017.05.14] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
Benign prostatic hyperplasia (BPH) is a common pathology causing lower urinary tract symptoms (LUTS) and may significantly impact quality of life. While transurethral resection of the prostate (TURP) remains the gold standard treatment, there are many evolving technologies that are gaining popularity. Photoselective vaporization of the prostate (PVP) is one such therapy which has been shown to be non-inferior to TURP. We aimed to review the literature and discuss factors to optimise patient outcomes in the setting of PVP for BPH. A comprehensive search of the electronic databases, including MEDLINE, Embase, Web of Science and The Cochrane Library was performed on articles published after the year 2000. After exclusion, a total of 38 papers were included for review. The evolution of higher powered device has enabled men with larger prostates and those on oral anticoagulation to undergo safely and successfully PVP. Despite continued oral anticoagulation in patients undergoing PVP, the risk of bleeding may be minimised with 5-Alpha Reductase Inhibitor (5-ARI) therapy however further studies are required. Pre-treatment with 5-ARI’s does not hinder the procedure however more studies are required to demonstrate a reliable benefit. Current data suggests that success and complication rate is largely influenced by the experience of the operator. Post-operative erectile dysfunction is reported in patients with previously normal function following PVP, however those with a degree of erectile dysfunction pre-operatively may see improvement with alleviation of LUTS.
Collapse
Affiliation(s)
- Claire Pascoe
- University of Melbourne, Department of Surgery, Austin Hospital, Melbourne, Australia.,Young Urology Researchers Organisation (YURO), Melbourne, Australia
| | - Darren Ow
- University of Melbourne, Department of Surgery, Austin Hospital, Melbourne, Australia.,Young Urology Researchers Organisation (YURO), Melbourne, Australia
| | - Marlon Perera
- University of Melbourne, Department of Surgery, Austin Hospital, Melbourne, Australia.,Young Urology Researchers Organisation (YURO), Melbourne, Australia
| | - Henry H Woo
- Sydney Adventist Hospital Clinical School, University of Sydney, Sydney, Australia
| | - Greg Jack
- University of Melbourne, Department of Surgery, Austin Hospital, Melbourne, Australia
| | - Nathan Lawrentschuk
- University of Melbourne, Department of Surgery, Austin Hospital, Melbourne, Australia.,Olivia Newton-John Cancer Research Institute, Melbourne, Australia.,Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
| |
Collapse
|
4
|
Wang SJ, Mu XN, Chen J, Jin XB, Zhang SB, Zhang LY. Plasmakinetic enucleation of prostate versus 160-W laser photoselective vaporization for the treatment of benign prostatic hyperplasia. Asian J Androl 2017; 19:15-19. [PMID: 26732101 PMCID: PMC5227666 DOI: 10.4103/1008-682x.164199] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
To evaluate the safety and efficacy of plasmakinetic enucleation of the prostate (PKEP) for the treatment of symptomatic benign prostatic hyperplasia (BPH) compared with 160-W lithium triboride laser photoselective vaporization of the prostate (PVP). From February 2011 to July 2012, a prospective nonrandomized study was performed. One-hundred one patients underwent PKEP, and 110 underwent PVP. No severe intraoperative complications were recorded, and none of the patients in either group required a blood transfusion. Shorter catheterization time (38.14 ± 23.64 h vs 72.54 ± 28.38 h, P < 0.001) and hospitalization (2.32 ± 1.25 days vs 4.07 ± 1.23 days, P < 0.001) were recorded in the PVP group. At 12-month postoperatively, the PKEP group had a maintained and statistically improvement in International Prostate Symptom Score (IPSS) (4.07 ± 2.07 vs 5.00 ± 2.10; P < 0.001), quality of life (QoL) (1.08 ± 0.72 vs 1.35 ± 0.72; P = 0.007), maximal urinary flow rate (Qmax) (24.75 ± 5.87 ml s−1vs 22.03 ± 5.04 ml s−1; P < 0.001), postvoid residual urine volume (PVR) (14.29 ± 6.97 ml vs 17.00 ± 6.11 ml; P = 0.001), and prostate-specific antigen (PSA) value (0.78 ± 0.57 ng ml−1vs 1.27 ± 1.07 ng ml−1; P < 0.001). Both PKEP and PVP relieve low urinary tract symptoms (LUTS) due to BPH with low complication rates. PKEP can completely remove prostatic adenoma while the total amount of tissue removed by PVP is less than that can be removed by PKEP. Based on our study of the follow-up, PKEP provides better postoperative outcomes than PVP.
Collapse
Affiliation(s)
- Si-Jun Wang
- Department of Urology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, P.R. China
| | - Xiao-Nan Mu
- Department of Concerning Foreign Affairs, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, P.R. China
| | - Ji Chen
- Department of Minimally Invasive Urology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, P.R. China
| | - Xun-Bo Jin
- Department of Minimally Invasive Urology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, P.R. China
| | - Shi-Bao Zhang
- Department of Urology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, P.R. China
| | - Long-Yang Zhang
- Department of Urology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, P.R. China
| |
Collapse
|
5
|
Elkoushy MA, Elhilali MM. Management of Benign Prostatic Hyperplasia Larger than 100 ml: Simple Open Enucleation Versus Transurethral Laser Prostatectomy. Curr Urol Rep 2016; 17:44. [PMID: 27048160 DOI: 10.1007/s11934-016-0601-7] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Benign prostatic hyperplasia (BPH) is one of the most common causes of lower urinary tract symptoms (LUTS) in aging men. Over the age of 60, more than a half of men have BPH and/or bothersome LUTS. Contemporary guidelines advocate surgery as the standard of care for symptomatic BPH after failure of medical therapy, where the choice of the appropriate surgical procedure depends on the prostate size. Transurethral resection of the prostate (TURP) and simple open prostatectomy (OP) have been considered for decades the reference-standard techniques for men with prostate smaller and larger than 80 ml, respectively. However, both procedures are potentially associated with considerable perioperative morbidity which prompted the introduction of a variety of minimally invasive surgical techniques with comparable long-term outcomes compared to TURP and OP. Nevertheless, the management of prostates larger than 100 ml remains a clinical challenge. Transurethral anatomical enucleation of the prostate utilizing different laser energy represents an excellent alternative concept in transurethral BPH surgery. These procedures gained popularity and demonstrated similar outcomes to OP with the advantages of favorable morbidity profiles and shorter catheter time and hospital stay. Despite the fact that OP remains a viable treatment option for patients with bothersome LUTS secondary to very large prostates, this procedure has been to a large extent replaced by these emerging enucleation techniques. Given the advent of surgical alternatives, the current review presents an evidence-based comparison of the efficacy and safety profile of the currently available transurethral laser techniques with the standard OP for the management of BPH due to adenomas larger than 100 ml.
Collapse
Affiliation(s)
- Mohamed A Elkoushy
- Department of Surgery, Division of Urology, Royal Victoria Hospital, McGill University Health Centre, 1001 Boulevard Decarie, D05.5327, Montreal, QC, Canada, H4A 3J1
- Department of Urology, Suez Canal University, Ismailia, Egypt
| | - Mostafa M Elhilali
- Department of Surgery, Division of Urology, Royal Victoria Hospital, McGill University Health Centre, 1001 Boulevard Decarie, D05.5327, Montreal, QC, Canada, H4A 3J1.
| |
Collapse
|
6
|
West KE, Woo HH. Does prostate size impact upon perioperative outcomes associated with photoselective vaporization of the prostate using the 180W lithium triborate laser? Urol Ann 2015; 7:17-20. [PMID: 25657537 PMCID: PMC4310110 DOI: 10.4103/0974-7796.148579] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2013] [Accepted: 04/01/2014] [Indexed: 11/21/2022] Open
Abstract
Introduction: Photoselective vaporization of the prostate (PVP) has been widely adopted as a surgical treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). Recently, a high-powered 180 W lithium triborate (LBO) laser has become commercially available and there is relatively little information on the impact of this very high-powered laser on perioperative outcomes. Even more so is the impact of the laser on outcomes according to prostate size. Objectives: The objective of this study was to evaluate perioperative outcomes after PVP with the 180W laser, relative to prostate size. Patients and Methods: A prospectively maintained institutional ethics approved database was retrospectively reviewed. Subjects were analyzed according to transrectal ultrasound and categorized into groups namely 0-39 mL, 40-79 mL, 80-120 mL and >120 mL. Perioperative measures included energy utilized, length of operation, duration catheterization, post operative length of stay (POLOS), Clavien-Dindo adverse events and number discharged home within 24 hours catheter free. Results: With increasing prostate size, there was a statistically significant increase in energy utilization and operation time (P < 0.01 between groups). Duration of catheterization, POLOS, incidence of Grade 3 and above Clavien-Dindo adverse events and discharge home catheter free within 24 hours was not statistically significant across groups. Conclusions: Prostate volume impacts upon energy utilized with PVP surgery. Prostate volume does not influence duration of catheterization or POLOS. Clavien-Dindo Grade 3 or greater adverse events were low and do not appear to be influenced by prostate size. The ability to be discharged home catheter free within 24 hours likewise does not appear to be influenced by prostate size.
Collapse
Affiliation(s)
- Kellie E West
- Sydney Adventist Hospital Clinical School, University of Sydney, Sydney, Australia
| | - Henry H Woo
- Sydney Adventist Hospital Clinical School, University of Sydney, Sydney, Australia
| |
Collapse
|
7
|
Long RM, Thomas AZ, Browne C, Alsinnawi M, Ul-islam J, McDermott TED, Grainger R, Thornhill JA. A 30-year experience of Millin's retropubic prostatectomy: Has this classic operation derived by a President of the College in Ireland stood the test of time? Ir J Med Sci 2014; 184:341-4. [PMID: 24729021 DOI: 10.1007/s11845-014-1115-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2013] [Accepted: 03/31/2014] [Indexed: 01/17/2023]
Abstract
INTRODUCTION In patients with large gland volume, open prostatectomy/adenoma enucleation remains a valuable surgical option in treating large obstructing prostates. We report our series of open prostatectomies spanning 32 years from a single institution. PATIENTS AND METHODS We retrospectively reviewed all patients who underwent open prostatectomy between 1980 and 2012. Patient demographical, clinical, pre- and postoperative data and final histology were retrieved from hospital in-patient enquiry system and chart review. RESULTS A total of 161 patients underwent Millin's prostatectomy by seven surgeons between 1980 and 2012. The mean blood loss was 1,381 mls (range 300-3,675 mls). One-third (34%) of patients (n = 55) received a blood transfusion. The mean weight of prostate tissue removed was 119 g (median 112 g, range 17-372 g). 6.6 % of pathological specimens revealed incidental prostate cancer, of which 78% were well differentiated (Gleason score ≤ 6). The mean weight of prostate tissue removed in patients who received a transfusion was 124 g. Trial of micturition (TOM) was performed at a mean of 9 days (median 9 days, range 5-25 days) with 94% of patients having a successful trial of voiding. 6% of cases early in the series failed to void initially, but did so at later removal of catheter while still in hospital. 45 patients (28%) of patients developed peri- or postoperative complications. There were three deaths (1.9%). CONCLUSION Open Millin's prostatectomy popularized over half a century ago continues to be a valuable option for the surgical treatment of high-volume prostate glands with excellent outcomes for patients.
Collapse
Affiliation(s)
- R M Long
- Department of Urology, The Adelaide and Meath Incorporating the National Children's Hospital (AMNCH), Tallaght, Dublin 24, Ireland
| | | | | | | | | | | | | | | |
Collapse
|
8
|
Rieken M, Bachmann A, Gratzke C. [Laservaporization of the prostate: current status of the greenlight and diode laser]. Urologe A 2013; 52:339-44. [PMID: 23429879 DOI: 10.1007/s00120-012-3087-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
In the last decade laser vaporization of the prostate has emerged as a safe and effective alternative to transurethral resection of the prostate (TURP). This was facilitated in particular by the introduction of photoselective vaporization of the prostate (PVP) with a 532 nm 80 W KTP laser in 2002. Prospective randomized trials comparing PVP and TURP with a maximum follow-up of 3 years mostly demonstrated comparable functional results. Cohort studies showed a safe application of PVP in patients under oral anticoagulation and with large prostates. Systems from various manufacturers with different maximum power output and wavelengths are now available for diode laser vaporization of the prostate. Prospective randomized trials comparing diode lasers and TURP are not yet available. In cohort studies and comparative studies PVP diode lasers are characterized by excellent hemostatic properties but functional results vary greatly with some studies reporting high reoperation rates.
Collapse
Affiliation(s)
- M Rieken
- Urologische Universitätsklinik Basel - Liestal, Universitätsspital Basel, Spitalstraße 21, CH-4031 Basel, Schweiz.
| | | | | |
Collapse
|
9
|
Strope SA, Yang L, Nepple KG, Andriole GL, Owens PL. Population based comparative effectiveness of transurethral resection of the prostate and laser therapy for benign prostatic hyperplasia. J Urol 2012; 187:1341-5. [PMID: 22341267 DOI: 10.1016/j.juro.2011.11.102] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2011] [Indexed: 01/21/2023]
Abstract
PURPOSE As the American population ages, benign prostatic hyperplasia and its associated lower urinary tract symptoms have become increasingly important causes of chronic morbidity. We assessed the comparative effectiveness of 2 common forms of surgical therapy, transurethral prostate resection and laser therapy, for benign prostatic hyperplasia. MATERIALS AND METHODS Using patient level discharge data and revisit files from the Agency for Healthcare Research and Quality we evaluated a cohort of patients who underwent transurethral prostate resection or laser therapy for benign prostatic hyperplasia in 2005 in California. Short-term outcomes, including in hospital complications, length of stay, 30-day rehospitalization, 30-day repeat surgery and 30-day emergency room visits, were compared between the therapies by regression analysis. Long-term re-treatment, defined as the absence of secondary procedures for benign prostatic hyperplasia or complications of therapy, was assessed by survival analysis. Analysis was adjusted for medical comorbidity, race, age and insurance status. RESULTS Data on 11,645 hospital discharges showed that mean length of stay was shorter for laser therapy than for transurethral prostate resection (0.70 vs 2.03 days, p<0.0001). The 30-day repeat visit occurred in 16% of laser and 17.7% of resection cases (p=0.0338). The 4-year re-treatment rate was 8.3% for resection and 12.8% for laser therapy (p<0.0001). After adjustment patients with resection were 37% less likely to require repeat therapy than those with laser therapy (HR 0.64, p<0.0001). CONCLUSIONS Laser procedures and transurethral prostate resection provide effective management of benign prostatic hyperplasia/lower urinary tract symptoms. Laser procedures are associated with less need for hospitalization than transurethral prostate resection but appear to involve a trade-off in long-term efficacy.
Collapse
Affiliation(s)
- Seth A Strope
- Division of Urology, Department of Surgery, Washington University, St. Louis, Missouri 63110, USA.
| | | | | | | | | |
Collapse
|